Latest Neuroblastoma Stories
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
For the first time, scientists at Fred Hutchinson Cancer Research Center have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy.
Ongoing research by a Baylor College of Medicine pediatric oncologist to understand how special cells called natural killer T (NKT) cells can be used to suppress neuroblastoma tumor growth has led to the discovery that the protein IL-15 is key to protecting the NKT cells' anti-tumor effectiveness in a hostile environment.
Around 80 percent of children with acute lymphoblastic leukemia (ALL) are now cured. With advancing treatment the cure rate may reach close to 90! Sounds promising right?
Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults.
Certain mutations of the gene ATRX were associated with age at diagnosis in children and young adults with advanced-stage neuroblastoma, a cancer that grows in parts of the nervous system.
A study by the Children's Oncology Group (COG) reported that five-year survival for acute lymphoblastic leukemia (ALL, the most common type of pediatric cancer) among children treated through COG clinical trials increased from 83.7 percent during the period 1990-1994 to 90.4 percent in the period 2000-2005.
- The parings of haberdine; also, any kind of fragments.